CLIA Kit for Interleukin 21 (IL21)

Za11

Specificity

This assay has high sensitivity and excellent specificity for detection of Interleukin 21 (IL21).
No significant cross-reactivity or interference between Interleukin 21 (IL21) and analogues was observed.

Recovery

Matrices listed below were spiked with certain level of recombinant Interleukin 21 (IL21) and the recovery rates were calculated by comparing the measured value to the expected amount of Interleukin 21 (IL21) in samples.

Matrix Recovery range (%) Average(%)
serum(n=5) 95-102 98
EDTA plasma(n=5) 81-97 88
heparin plasma(n=5) 90-97 94

Precision

Intra-assay Precision (Precision within an assay): 3 samples with low, middle and high level Interleukin 21 (IL21) were tested 20 times on one plate, respectively.
Inter-assay Precision (Precision between assays): 3 samples with low, middle and high level Interleukin 21 (IL21) were tested on 3 different plates, 8 replicates in each plate.
CV(%) = SD/meanX100
Intra-Assay: CV<10%
Inter-Assay: CV<12%

Linearity

The linearity of the kit was assayed by testing samples spiked with appropriate concentration of Interleukin 21 (IL21) and their serial dilutions. The results were demonstrated by the percentage of calculated concentration to the expected.

Sample 1:2 1:4 1:8 1:16
serum(n=5) 96-103% 79-93% 89-102% 96-104%
EDTA plasma(n=5) 93-105% 87-102% 89-103% 90-104%
heparin plasma(n=5) 84-92% 78-88% 85-96% 91-105%

Stability

The stability of kit is determined by the loss rate of activity. The loss rate of this kit is less than 5% within the expiration date under appropriate storage condition.
To minimize extra influence on the performance, operation procedures and lab conditions, especially room temperature, air humidity, incubator temperature should be strictly controlled. It is also strongly suggested that the whole assay is performed by the same operator from the beginning to the end.

Reagents and materials provided

Reagents Quantity Reagents Quantity
Pre-coated, ready to use 96-well strip plate 1 Plate sealer for 96 wells 4
Standard 2 Standard Diluent 1×20mL
Detection Reagent A 1×120µL Assay Diluent A 1×12mL
Detection Reagent B 1×120µL Assay Diluent B 1×12mL
Substrate A 1×10mL Substrate B 1×2mL
Wash Buffer (30 × concentrate) 1×20mL Instruction manual 1

Assay procedure summary

1. Prepare all reagents, samples and standards;
2. Add 100µL standard or sample to each well. Incubate 1 hours at 37°C;
3. Aspirate and add 100µL prepared Detection Reagent A. Incubate 1 hour at 37°C;
4. Aspirate and wash 3 times;
5. Add 100µL prepared Detection Reagent B. Incubate 30 minutes at 37°C;
6. Aspirate and wash 5 times;
7. Add 100µL Substrate Solution. Incubate 10 minutes at 37°C;
8. Read RLU value immediately.

GIVEAWAYS

INCREMENT SERVICES

Magazine Citations
Neurological Sciences Serum IL-21 levels decrease with glucocorticoid treatment in myasthenia gravis Pubmed: 23708911
Physiological Research Pre-Press Article Decrease in serum interleukin 21 levels is associated with disease activity improvement in patients with recent-onset rheumatoid arthritis Biomed: Source
Catalog No. Related products for research use of Homo sapiens (Human) Organism species Applications (RESEARCH USE ONLY!)
APB688Hu01 Active Interleukin 21 (IL21) Cell culture; Activity Assays.
RPB688Hu01 Recombinant Interleukin 21 (IL21) Positive Control; Immunogen; SDS-PAGE; WB.
RPB688Hu02 Recombinant Interleukin 21 (IL21) Positive Control; Immunogen; SDS-PAGE; WB.
PAB688Hu01 Polyclonal Antibody to Interleukin 21 (IL21) WB; IHC; ICC; IP.
PAB688Hu02 Polyclonal Antibody to Interleukin 21 (IL21) WB; IHC; ICC; IP.
LAB688Hu71 Biotin-Linked Polyclonal Antibody to Interleukin 21 (IL21) WB; IHC; ICC.
LAB688Hu81 FITC-Linked Polyclonal Antibody to Interleukin 21 (IL21) WB; IHC; ICC; IF.
MAB688Hu22 Monoclonal Antibody to Interleukin 21 (IL21) WB; IHC; ICC; IP.
SEB688Hu ELISA Kit for Interleukin 21 (IL21) Enzyme-linked immunosorbent assay for Antigen Detection.
SCB688Hu CLIA Kit for Interleukin 21 (IL21) Chemiluminescent immunoassay for Antigen Detection.